CLINICAL-GRADE TUMOR AND LONGITUDINAL CELL-FREE DNA/RNA MOLECULAR PROFILING TO OPTIMIZE TREATMENT IN LETHAL NONCASTRATE PROSTATE CANCER...ENTERED ON 7/30/2019 AS FORMULA GRANT, CORRECTED ON 11/20/2019
$1,318,736FY2019Defense Health AgencyDOD
Sloan-Kettering Institute For Cancer Research